Drawing for ONCORESPONSE

USPTO serial 86719926

ONCORESPONSE

Reviewed by CopyMark Law Group

Reg. 5069797Status 702Renewal
Filing date
Status date
Registration date
Oct 25, 2016
Examiner
WELLS, KELLEY L
Law office
TMO LAW OFFICE 118

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ONCORESPONSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tiffany D. Gehrke

Tiffany D. Gehrke Marshall, Gerstein & Borun LLP233 S Wacker Drive6300 Willis TowerChicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
042Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical drug development services; Drug discovery services; and Pharmaceutical research and developmentACTIVEOct 1, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 26, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Apr 22, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Apr 22, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 22, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 13, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Oct 25, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 25, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 22, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 21, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 20, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 19, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 25, 2016IUAFUSE AMENDMENT FILED—
Aug 25, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 1, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 5, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 5, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 16, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 20, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 20, 2015DOCKASSIGNED TO EXAMINER—
Aug 14, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Aug 13, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 13, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance